Cargando…

First person – David Pirovich

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104855/
http://dx.doi.org/10.1242/bio.051631
_version_ 1783512299804295168
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances formation of the blood-clot lysis protein plasmin’, published in BiO. David is a PhD candidate in the lab of Dr Patrick Skelly at Tufts University, North Grafton, MA, USA, investigating novel moonlighting functions (thrombolysis, immunomodulation) of Schistosoma mansoni glycolytic enzymes.
format Online
Article
Text
id pubmed-7104855
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-71048552020-03-31 First person – David Pirovich Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open (BiO), helping early-career researchers promote themselves alongside their papers. David Pirovich is first author on ‘Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase enhances formation of the blood-clot lysis protein plasmin’, published in BiO. David is a PhD candidate in the lab of Dr Patrick Skelly at Tufts University, North Grafton, MA, USA, investigating novel moonlighting functions (thrombolysis, immunomodulation) of Schistosoma mansoni glycolytic enzymes. The Company of Biologists Ltd 2020-03-24 /pmc/articles/PMC7104855/ http://dx.doi.org/10.1242/bio.051631 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – David Pirovich
title First person – David Pirovich
title_full First person – David Pirovich
title_fullStr First person – David Pirovich
title_full_unstemmed First person – David Pirovich
title_short First person – David Pirovich
title_sort first person – david pirovich
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104855/
http://dx.doi.org/10.1242/bio.051631